On April 5, 2024, Novo Nordisk A/S executives reported their purchase of shares: Douglas Langa bought 24.862 ADRs at DKK 865.68 (total DKK 21,522.51) and 7.904 ADRs at DKK 864.99 (total DKK 6,836.92). This filing is significant for investors as it shows insider trading activities.